Connect with us

Health

Antibody to SARS-CoV-2 inhibits complement hyperactivation – News-Medical.Net

Although several monoclonal antibodies against the SARS-CoV-2 spike protein have been developed and clinically tested, little is known about antibodies to the nucleocapsid…

Published

on

Article feature image
ADVERTISEMENT

Researchers identified several antibodies to the nucleocapsid protein from a convalescent COVID-19 patient. Tests found some can inhibit complement hyperactivation and could potentially lead to new therapeutics.
Approximately half of all patients with severe COVID-19 disease develop acute respiratory distress, which can be fatal. Some patients also have symptoms similar to acute respiratory distress syndrome (ARDS). Studies have suggested that a hyperactive complement system, a part of the immune…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Unlinked Vic COVID case, low test concerns – St George and Sutherland Shire Leader
Article feature image
With a little help from friends, women over 50 stare down vaccine fears – Sydney Morning Herald